# EnteroBiotix

**Source:** https://www.startuphub.ai/startups/enterobiotix
**Profile type:** Startup

> Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

## About

EnteroBiotix is a clinical-stage microbiome therapeutics company focused on transforming the standard of care for patients with gastrointestinal disease. Their lead investigational product, EBX-102-02, is an orally delivered, full-spectrum microbiome drug in clinical development for irritable bowel syndrome (IBS) and other gastrointestinal and liver-related diseases. EBX-102-02 is a high-diversity microbial product manufactured using proprietary AMPLA™ drying technology.

## Key facts

- **Slug:** enterobiotix
- **Website:** https://www.enterobiotix.com/
- **Location:** Glasgow, United Kingdom
- **Founded:** 2017-01-01T00:00:00
- **Operating status:** Active
- **Total funding:** $41M
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Healthcare, Life Sciences, Microbiome, Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Microbiome Engineering, Gastrointestinal Health
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/enterobiotiix/
  - Twitter: http://x.com/enterobiotix
  - Facebook: http://www.facebook.com/2008

## Frequently asked

### What does EnteroBiotix do?

EnteroBiotix is a clinical-stage microbiome therapeutics company focused on transforming the standard of care for patients with gastrointestinal disease. Their lead investigational product, EBX-102-02, is an orally delivered, full-spectrum microbiome drug in clinical development for irritable bowel syndrome (IBS) and other gastrointestinal and liver-related diseases. EBX-102-02 is a high-diversity microbial product manufactured using proprietary AMPLA™ drying technology.

### What is EnteroBiotix's revenue?

StartupHub estimates EnteroBiotix's annual revenue at $5.1M (range $1.8M to $17.7M, 34% confidence), based on comparable companies in the sector.

### What is EnteroBiotix's valuation?

StartupHub estimates EnteroBiotix's effective valuation at $152.3M (range $101.3M to $243.0M, 23% confidence), based on comparable companies in the sector.

### How much funding has EnteroBiotix raised?

EnteroBiotix has raised a total of $41M in funding. The most recent round on record is Funding Round.

### Where is EnteroBiotix headquartered?

EnteroBiotix is headquartered in Glasgow, United Kingdom.

### When was EnteroBiotix founded?

EnteroBiotix was founded in 2017.

### What industry does EnteroBiotix operate in?

EnteroBiotix operates in Biotechnology, Pharmaceuticals, Healthcare, Life Sciences, Microbiome, Biotech.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "EnteroBiotix",
          "item": "https://www.startuphub.ai/startups/enterobiotix"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/enterobiotix#webpage",
      "url": "https://www.startuphub.ai/startups/enterobiotix",
      "name": "EnteroBiotix - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of EnteroBiotix. EnteroBiotix is a startup founded in 2017, operating in Biotechnology and Pharmaceuticals. Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health. Headquartered in Glasgow, United Kingdom.",
      "dateModified": "2026-07-01T09:30:43.137864+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/enterobiotix#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/enterobiotix#organization",
      "name": "EnteroBiotix",
      "url": "https://www.enterobiotix.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/77760ecf-8e40-45de-b196-1fad90ef66fb-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/77760ecf-8e40-45de-b196-1fad90ef66fb-square.webp",
      "description": "This is the official profile of EnteroBiotix. EnteroBiotix is a startup founded in 2017, operating in Biotechnology and Pharmaceuticals. Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health. Headquartered in Glasgow, United Kingdom.",
      "sameAs": [
        "https://www.linkedin.com/company/enterobiotiix/",
        "http://x.com/enterobiotix",
        "http://www.facebook.com/2008",
        "https://www.startuphub.ai/startups/enterobiotix"
      ],
      "foundingDate": "2017-01-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Glasgow",
        "addressCountry": "GB"
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Healthcare",
        "Life Sciences",
        "Microbiome",
        "Biotech",
        "MedTech",
        "HealthTech",
        "Drug Discovery",
        "Clinical Trials",
        "Microbiome Engineering",
        "Gastrointestinal Health"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/enterobiotix#profile-assessment",
      "name": "EnteroBiotix - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/enterobiotix",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/77760ecf-8e40-45de-b196-1fad90ef66fb-square.webp",
      "category": "Biotechnology",
      "description": "This is the official profile of EnteroBiotix. EnteroBiotix is a startup founded in 2017, operating in Biotechnology and Pharmaceuticals. Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health. Headquartered in Glasgow, United Kingdom. Agent Readiness score: 45/100. Full audit: https://www.startuphub.ai/startups/enterobiotix/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "EnteroBiotix"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-07-01",
        "name": "EnteroBiotix - Profile Score 50/100",
        "reviewBody": "This is the official profile of EnteroBiotix. EnteroBiotix is a startup founded in 2017, operating in Biotechnology and Pharmaceuticals. Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health. Headquartered in Glasgow, United Kingdom. Agent Readiness score: 45/100. Full audit: https://www.startuphub.ai/startups/enterobiotix/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 50,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```